日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

HELZ2 Regulates Apob mRNA Stability to Modulate Fatty Liver Disease and Atherosclerosis.

HELZ2 调节 Apob mRNA 稳定性以调节脂肪肝疾病和动脉粥样硬化。

Publisher Correction: APOBEC3 mutagenesis drives therapy resistance in breast cancer

出版商更正:APOBEC3 突变驱动乳腺癌治疗耐药性

Gupta, Avantika; Gazzo, Andrea; Selenica, Pier; Safonov, Anton; Pareja, Fresia; da Silva, Edaise M; Brown, David N; Shao, Hong; Zhu, Yingjie; Patel, Juber; Blanco-Heredia, Juan; Stefanovska, Bojana; Carpenter, Michael A; Chen, Yanjun; Vegas, Isabella; Pei, Xin; Frosina, Denise; Jungbluth, Achim A; Ladanyi, Marc; Curigliano, Giuseppe; Weigelt, Britta; Riaz, Nadeem; Powell, Simon N; Razavi, Pedram; Harris, Reuben S; Reis-Filho, Jorge S; Marra, Antonio; Chandarlapaty, Sarat

Guardian ubiquitin E3 ligases target cancer-associated APOBEC3 deaminases for degradation to promote human genome integrity

守护者泛素E3连接酶靶向癌症相关的APOBEC3脱氨酶进行降解,从而促进人类基因组的完整性。

Schwartz, Irene; Budroni, Valentina; Meyenberg, Mathilde; Hodakova, Zuzana; Hornegger, Harald; Hacker, Kathrin; Schwartz, Siegfried; Grabarczyk, Daniel B; Ehrmann, Julian F; Scinicariello, Sara; Haselbach, David; Menche, Jörg; Clausen, Tim; Karagöz, G Elif; Versteeg, Gijs A

R-loop editing by DNA cytosine deaminase APOBEC3B modulates the activity of oestrogen receptor enhancers.

DNA胞嘧啶脱氨酶APOBEC3B对R环的编辑调节雌激素受体增强子的活性。

Zhang Chi, Lu Yu-Jing, Chen Bingjie, Bai Zhiyan, Zeng Qiaoxi, Hervieu Alexia, Licciardello Marco P, Mitsopoulos Konstantinos, Al-Lazikani Bissan, Tortorici Marcello, Rossanese Olivia W, Workman Paul, Clarke Paul A

Carriage of rare APOB variants predisposes to severe steatotic liver disease and hepatocellular carcinoma

携带罕见APOB变异基因会增加罹患严重脂肪肝和肝细胞癌的风险。

Mureddu, Matteo; Pelusi, Serena; Jamialahmadi, Oveis; Vujkovic, Marijana; Miano, Lorenzo; Eidgah Torghabehei, Hadi; Ronzoni, Luisa; Malvestiti, Francesco; Saracino, Marco; Periti, Giulia; Moretti, Vittoria; Teerlink, Craig C; Lynch, Julie A; Tsao, Philip S; Johnson, Josephine P; La Mura, Vincenzo; Dilena, Robertino; Alqahtani, Saleh A; Cherubini, Alessandro; Russo, Francesco Paolo; D'Ambrosio, Roberta; Fraquelli, Mirella; Petta, Salvatore; Miele, Luca; Vespasiani-Gentilucci, Umberto; Bugianesi, Elisabetta; Mancina, Rosellina M; Parini, Paolo; Prati, Daniele; Chang, Kyong-Mi; Schneider, Carolin V; Romeo, Stefano; Valenti, Luca Vc

HAMMER: hairpin-based APOBEC3A-mediated mRNA editing reporter

HAMMER:基于发夹结构的APOBEC3A介导的mRNA编辑报告基因

Chen, Yanjun; Mullally, Christopher D; Stefanovska, Bojana; Harris, Reuben S

hnRNPA2B1 induces HBV cccDNA degradation by recruiting APOBEC3B.

hnRNPA2B1 通过募集 APOBEC3B 诱导 HBV cccDNA 降解。

Fu Zhendong, Wang Liyuan, Sun Yang, Ren Caiyue, Dou Yutong, Wang Kai, Fan Yuchen, Yue Xuetian, Li Chunyang, Gao Lifen, Liang Xiaohong, Ma Chunhong, Wu Zhuanchang

APOBEC3C coordinates DDX5 in R-loop resolution and dynamic control of Chk1-mediated stress-responsive circuitry as a prerequisite for gemcitabine resistance in p53-deficient cells.

APOBEC3C 协调 DDX5 进行 R 环解析和 Chk1 介导的应激反应回路的动态控制,这是 p53 缺陷细胞对吉西他滨产生耐药性的先决条件。

Tao Li, Zhao Yang, Jiang Zhuangzhaung, Kong Shujing, Ding Yanlin, Ni Tengyang, Wang Weimin, Liu Yanqing

Correction to: Elevated APOBEC3B expression drives a kataegic-like mutation signature and replication stress-related therapeutic vulnerabilities in p53-defective cells

更正:APOBEC3B 表达升高驱动 p53 缺陷细胞中类似 kataegic 的突变特征和复制应激相关的治疗脆弱性

Nikkilä, Jenni; Kumar, Rahul; Campbell, James; Brandsma, Inger; Pemberton, Helen N; Wallberg, Fredrik; Nagy, Kinga; Scheer, Ildikó; Vertessy, Beata G; Serebrenik, Artur A; Monni, Valentina; Harris, Reuben S; Pettitt, Stephen J; Ashworth, Alan; Lord, Christopher J

Reprogramming tumor immunity through APOBEC3s-mediated mutagenesis: from genome instability to immune checkpoint interactions

通过APOBEC3s介导的诱变重编程肿瘤免疫:从基因组不稳定性到免疫检查点相互作用

Li, Qiaoxi; Wan, Wenyu; Zhu, Zihan; Lin, Xuanduo; Wang, Fei; Li, Mengmeng; Guo, Hao; Yang, Yang